Starling Oncology (STLNW) FCF Margin (2021 - 2026)
Starling Oncology's (STLNW) quarterly FCF Margin came in at 6.84% in Q2 2026, up 1636.0% on a YoY basis from 0.39% in Q2 2025, and up 409.65% quarter-over-quarter from 2.21% in Q1 2026.
Powered by 
Analysis
Starling Oncology (STLNW) FCF Margin (2021 - 2026) Analysis & Trends
Starling Oncology (STLNW) has reported FCF Margin for 6 consecutive years, with 6.84% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, FCF Margin rose 1636.0% year-over-year to 6.84%; the trailing twelve-month figure through Jun 2026 stood at 0.56% (up 257.0% YoY), and the FY2025 full-year result was 5.53%, up 218.0% from the prior year.
- FCF Margin grew to 6.84% in Q2 2026 per STLNW's latest filing, from 2.21% in the prior quarter.
- Across five years, FCF Margin topped out at 6.84% in Q2 2026 and bottomed at 33.23% in Q3 2022.
- Historically, FCF Margin has averaged 11.6% across 5 years, with a median of 10.48% in 2023.
- The widest YoY moves for FCF Margin: up 2389 bps in 2022, down 3228 bps in 2022.
- Over 5 years, FCF Margin stood at 22.39% in 2022, then jumped by 75 bps to 5.54% in 2023, then soared by 140 bps to 2.24% in 2024, then slumped by 32 bps to 1.53% in 2025, then jumped by 347 bps to 6.84% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 6.84%, 2.21%, and 1.53% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.89 Bn | 11.20 Bn | 1.16 Bn | 9.01% |
| 2 | RadNet | 5.51 Bn | 4.78 Bn | 88.08 Mn | 13.26% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | 17.70% |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | 19.73% |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | 0.25% |
| 6 | Pediatrix Medical | 2.14 Bn | 1.74 Bn | - | 25.41% |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn | 12.61% |
| 8 | Surgery Partners | 1.85 Bn | 1.63 Bn | 622.10 Mn | 4.42% |
| 9 | U S Physical Therapy | 1.18 Bn | 1.15 Bn | 41.94 Mn | 13.55% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | 6.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.84% |
| Mar 31, 2026 | -2.21% |
| Dec 31, 2025 | 1.53% |
| Sep 30, 2025 | -9.69% |
| Jun 30, 2025 | -9.52% |
| Mar 31, 2025 | -5.09% |
| Dec 31, 2024 | 2.24% |
| Sep 30, 2024 | 1.22% |
| Jun 30, 2024 | -17.74% |
| Mar 31, 2024 | -17.42% |
| Dec 31, 2023 | -5.54% |
| Sep 30, 2023 | -11.26% |
| Jun 30, 2023 | -11.96% |
| Mar 31, 2023 | -22.69% |
| Dec 31, 2022 | -22.39% |
| Sep 30, 2022 | -33.23% |
| Jun 30, 2022 | -19.24% |
| Mar 31, 2022 | -32.60% |
| Dec 31, 2021 | -46.28% |
| Sep 30, 2021 | -6.94% |